在心律失常基因KCNE1中变异的高通量功能映射揭示了新的生物学
Ayesha Muhammad1,2, Maria E Calandranis3, Bian Li3,4
1Vanderbilt Genetics Institute, Vanderbilt University Medical Center, 1235 Medical Research Building IV, 2215B Garland Avenue, Nashville, TN, 37232, USA.
Genome medicine
|May 30, 2024
概括
这项研究绘制了成千上万的KCNE1变异,揭示了许多损害心脏通道 (IKs) 功能. 这些发现有助于理解长QT综合征和心房动,并重新分类遗传变异.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子生物学分子生物学
- 道病变是一种通道病变.
背景情况:
- KCNE1编码心脏通道IKs的一个子单元,这对心律至关重要.
- KCNE1变异与长QT综合征和心房动有关,但许多变异缺乏明确的临床意义.
- 目前对KCNE1变种致病性的理解有限,这阻碍了临床实用性.
研究的目的:
- 通过使用变异效应映射,全面地绘制数千种编码蛋白质的KCNE1变体的功能影响.
- 识别影响IKs通道表面表达和功能的变异.
- 为重新分类具有不确定的意义的变异提供数据,并提高临床效用.
主要方法:
- 采用变异效应映射,将和突变发生与高通量测序相结合.
- 对2500多种KCNE1变体进行了细胞表面表达和功能测试.
- 与电生理学,人口队列和计算预测对比的验证功能测试数据.
主要成果:
- 确定了470种影响表面表达的变种和574种影响功能的变种.
- 发现大多数功能上有害的变种影响道封锁而不是贩运.
- 发现KCNE1蛋白的后半部分对功能至关重要,但不是贩运.
- 突出不容忍变化的残留物经常与KCNQ1或calmodulin相互作用.
结论:
- 综合的KCNE1变异效应图提供了对IKs通道生物学的洞察.
- 这些地图可以帮助重新分类具有不确定的意义的变异.
- 这项研究提供了支持美国医学遗传学院/分子病理学协会变种分类标准的证据.
更多相关视频
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.0K
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
1.2K
相关概念视频
Mechanism of Cardiac Arrhythmias
2.8K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.8K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
